Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |